Tactical

• Research type

  Research Study

• Full title

  A Phase I/II randomised study of Tarceva (Elotonib), used concurrently with thoracic radiation in patients with advanced non-small cell lung cancer.

• IRAS ID

  2658

• Contact name

  Stephen Mangar

• Contact email

  s.mangar@imperial.ac.uk

• Sponsor organisation

  Imperial College NHS Healthcare Trust

• Eudract number

  2008-001431-35

• ISRCTN Number

  N/A

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  08/H1208/41

• Date of REC Opinion

  14 Oct 2008

• REC opinion

  Further Information Favourable Opinion